General Information of DTT (ID: TTCQ2E5)

DTT Name RIP2 messenger RNA (RIP2 mRNA) DTT Info
UniProt ID
RIPK2_HUMAN
Gene Name RIPK2

Molecule-Related Drug & Molecule List

Molecule-Related Drug List
Molecule Type:
DTT
DTP
DME
Drug Status:
Clinical Trial Drug(s)
Investigative Drug(s)
1 Clinical Trial Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
ISIS-CRP DMQDUG4 Cardiovascular disease BA00-BE2Z Phase 1 [1]
------------------------------------------------------------------------------------
9 Investigative Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
ISIS 104211 DMPKQ61 Discovery agent N.A. Investigative [2]
ISIS 104253 DMME8JP Discovery agent N.A. Investigative [2]
ISIS 104254 DMDEI9X Discovery agent N.A. Investigative [2]
ISIS 104255 DMAI5B8 Discovery agent N.A. Investigative [2]
ISIS 104256 DMHUX9A Discovery agent N.A. Investigative [2]
ISIS 104257 DMSDCGV Discovery agent N.A. Investigative [2]
ISIS 104258 DMUC3L0 Discovery agent N.A. Investigative [2]
NM-PP1 DMS8H5Q Discovery agent N.A. Investigative [1]
Src kinase inhibitor I DMUZP9V Discovery agent N.A. Investigative [1]
------------------------------------------------------------------------------------
⏷ Show the Full List of 9 Investigative Drug(s)
Molecule Interaction Atlas

References

1 The selectivity of protein kinase inhibitors: a further update. Biochem J. 2007 Dec 15;408(3):297-315.
2 US patent application no. 6,426,221, Antisense modulation of RIP2 expression.